Results 241 to 250 of about 69,470 (266)

CLSI Releases Updated Guideline for the Development of Immunohistochemical Assays

Applied Immunohistochemistry & Molecular Morphology, 2011
Melissa, D'Archangelo, Stephen, Hewitt, Max, Robinowitz   +2 more
openaire   +2 more sources

Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans.

Antimicrobial Agents and Chemotherapy, 2020
Abdullah M.S. Al-Hatmi, Gerrit Sybren de Hoog, Paul E. Verweij   +2 more
exaly  

CLSI News

Clinical Microbiology Newsletter, 2009
openaire   +1 more source

EUCAST-CLSI for yeast: Differences in methods and interpretation [EUCAST-CLSI: Differenze analitiche ed interpretative per i lieviti]

2010
no ...
openaire   +2 more sources

Comparison of antimicrobial susceptibility interpretation among Enterobacteriaceae using CLSI and EUCAST breakpoints

Indian Journal of Medical Microbiology, 2021
Vivek Hada, Dr SWATHI SURAVARAM
exaly  

New CLSI Documents

Clinical Microbiology Newsletter, 2008
openaire   +1 more source

CLSI ANNOUNCES A NEW DEVELOPMENT PATH

VINE, 1987
openaire   +1 more source

Head‐to‐head comparison of CLSI, EUCAST, Etest and VITEK®2 results for susceptibility testing

International Journal of Antimicrobial Agents, 2022
José Yesid Rodríguez, Patrice Le Pape, Carlos Arturo Alvarez Moreno   +2 more
exaly  

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and : Time for harmonization of CLSI and EUCAST broth microdilution methods

Drug Resistance Updates, 2010
David Andes, Daniel J. Diekema, A Espinel-Ingroff   +2 more
exaly  

Changes in the CLSI Interpretive Criteria for Enterobacteriaceae and Ertapenem

Clinical Microbiology Newsletter, 2011
Robert E. Badal, James S. Lewis, Mary R. Motyl   +2 more
openaire   +1 more source